Bio Impact Capital LLC Compass Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $623 Million
- Q2 2024
A detailed history of Bio Impact Capital LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 5,005,086 shares of CMPX stock, worth $9.06 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
5,005,086
Previous 1,971,402
153.88%
Holding current value
$9.06 Million
Previous $3.9 Million
28.23%
% of portfolio
0.8%
Previous 0.64%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
82Shares Held
92.8MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$40.5 Million0.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$20.1 Million0.02% of portfolio
-
Blackstone Inc New York, NY7.69MShares$13.9 Million0.03% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$12 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.51MShares$9.98 Million0.17% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $183M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...